Competition, not need, drives hospital cardiac care investment
U.S. hospitals spent up to $4 billion adding angioplasty services over a four year period, but the new services did little to improve access to timely medical care, says a study published Tuesday in the journal Circulation. Between 2004 to 2008, some 251 hospitals added the invasive and often life-saving cardiac care, but researchers found that the new programs were mainly built near existing ones in competitive healthcare markets, rather than where the need for the services was greatest. The percent of the U.S. population with timely access to angioplasty—a drive time of under one hour—improved by less than 2 percent during the study period. At the same time, the number of hospital-based cardiac labs and clinics increased by 16 percent, the study found. The millions of dollars hospitals have spent adding the services led to higher insurance premiums for everyone, researchers concluded.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- WellPoint Dominates Nearly Half of Markets, AMA Says
- Defensive Medicine Still Prevalent Despite Tort Reform
- CMS Offers Some ACOs $114M for 'Upfront' Costs